$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

$ssy Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-K Financial Statement

#000119312517297905 Filed on September 28, 2017

Income Statement

Concept	2017 Q2	2017	2016 Q2
Revenue	$12.29M	$53.29M	$14.06M
YoY Change	-12.6%	-15.99%	-23.89%
Cost Of Revenue	$4.330M	$19.92M	$4.820M
YoY Change	-10.17%	513.21%	0.63%
Gross Profit	$7.960M	$33.37M	-$2.120M
YoY Change	-475.47%	-44.55%	-2220.0%
Gross Profit Margin	64.78%	62.62%	-15.08%
Selling, General & Admin	$7.280M	$28.99M
YoY Change		-25.25%
% of Gross Profit	91.46%	86.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$540.0K	$1.987M	$2.440M
YoY Change	-77.87%	-18.43%	-8.96%
% of Gross Profit	6.78%	5.95%
Operating Expenses	$9.340M	$57.36M	-$1.500M
YoY Change	-722.67%	17.8%	2042.86%
Operating Profit	-$1.380M	-$4.510M	-$620.0K
YoY Change	122.58%	-30.86%	-464.71%
Interest Expense	-$130.0K	$635.0K	-$210.0K
YoY Change	-38.1%	-24.67%	16.67%
% of Operating Profit
Other Income/Expense, Net	$1.540M		-$1.600M
YoY Change	-196.25%		416.13%
Pretax Income	-$3.040M	-$2.471M	-$1.690M
YoY Change	79.88%	-66.41%
Income Tax	-$280.0K	-$512.0K	-$2.290M
% Of Pretax Income
Net Earnings	-$2.408M	$2.688M	-$1.234M
YoY Change	95.14%	-119.09%	-1441.3%
Net Earnings / Revenue	-19.6%	5.04%	-8.78%
Basic Earnings Per Share	-$0.26	$0.29	-$0.13
Diluted Earnings Per Share	-$0.26	$0.29	-$0.13
COMMON SHARES
Basic Shares Outstanding	9.163M shares	9.346M shares	9.443M shares
Diluted Shares Outstanding	9.163M shares	9.346M shares	9.443M shares

Balance Sheet

Concept	2017 Q2	2017	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.50M	$10.49M	$3.300M
YoY Change	218.18%	221.8%	-45.0%
Cash & Equivalents	$10.49M	$10.49M	$3.261M
Short-Term Investments
Other Short-Term Assets	$4.100M	$4.062M	$5.900M
YoY Change	-30.51%	-30.6%	-28.92%
Inventory	$2.159M	$2.159M	$2.612M
Prepaid Expenses
Receivables	$5.900M	$5.906M	$6.200M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$22.62M	$22.62M	$17.89M
YoY Change	26.43%	26.43%	-28.69%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.29M	$10.29M	$12.99M
YoY Change	-20.81%	-20.81%	-8.77%
Goodwill	$0.00		$461.0K
YoY Change	-100.0%		0.0%
Intangibles	$1.587M		$2.695M
YoY Change	-41.11%		-5.01%
Long-Term Investments
YoY Change
Other Assets	$838.0K	$838.0K	$732.0K
YoY Change	14.48%	-91.67%	-51.84%
Total Long-Term Assets	$12.72M	$12.72M	$26.21M
YoY Change	-51.49%	-51.49%	-18.18%
TOTAL ASSETS
Total Short-Term Assets	$22.62M	$22.62M	$17.89M
Total Long-Term Assets	$12.72M	$12.72M	$26.21M
Total Assets	$35.34M	$35.34M	$44.11M
YoY Change	-19.88%	-19.88%	-22.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.571M	$1.571M	$3.391M
YoY Change	-53.67%	-53.67%	26.15%
Accrued Expenses	$658.0K	$3.375M	$1.883M
YoY Change	-65.06%	-25.94%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.710M	$6.710M	$7.473M
YoY Change	-10.21%	-10.21%	815.81%
Total Short-Term Liabilities	$12.31M	$12.31M	$20.05M
YoY Change	-38.59%	-38.59%	86.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$2.979M
YoY Change	-100.0%	-100.0%	-73.47%
Other Long-Term Liabilities	$289.0K	$1.329M	$425.0K
YoY Change	-32.0%	-16.2%	-37.59%
Total Long-Term Liabilities	$1.329M	$1.329M	$4.565M
YoY Change	-70.89%	-70.89%	-64.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.31M	$12.31M	$20.05M
Total Long-Term Liabilities	$1.329M	$1.329M	$4.565M
Total Liabilities	$13.64M	$13.64M	$24.62M
YoY Change	-44.58%	-44.58%	4.45%
SHAREHOLDERS EQUITY
Retained Earnings	$4.336M		$1.648M
YoY Change	163.11%		-89.52%
Common Stock	$17.68M		$18.26M
YoY Change	-3.16%		0.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.70M	$21.69M	$19.50M
YoY Change
Total Liabilities & Shareholders Equity	$35.34M	$35.34M	$44.11M
YoY Change	-19.88%	-19.88%	-22.8%

Cashflow Statement

Concept	2017 Q2	2017	2016 Q2
OPERATING ACTIVITIES
Net Income	-$2.408M	$2.688M	-$1.234M
YoY Change	95.14%	-119.09%	-1441.3%
Depreciation, Depletion And Amortization	$540.0K	$1.987M	$2.440M
YoY Change	-77.87%	-18.43%	-8.96%
Cash From Operating Activities	-$610.0K	-$5.610M	-$140.0K
YoY Change	335.71%	1216.9%	-108.48%
INVESTING ACTIVITIES
Capital Expenditures	-$530.0K	$1.630M	-$260.0K
YoY Change	103.85%	21.01%	-13.33%
Acquisitions
YoY Change
Other Investing Activities	$540.0K	$20.10M	$20.00K
YoY Change	2600.0%	95609.52%	-33.33%
Cash From Investing Activities	$0.00	$18.47M	-$240.0K
YoY Change	-100.0%	-1391.54%	-11.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$641.0K
YoY Change
Debt Paid & Issued, Net		$3.985M
YoY Change		364.99%
Cash From Financing Activities	-140.0K	-5.626M	-260.0K
YoY Change	-46.15%	556.48%	-7.14%
NET CHANGE
Cash From Operating Activities	-610.0K	-5.610M	-140.0K
Cash From Investing Activities	0.000	18.47M	-240.0K
Cash From Financing Activities	-140.0K	-5.626M	-260.0K
Net Change In Cash	-750.0K	7.233M	-640.0K
YoY Change	17.19%	-366.61%	-158.18%
FREE CASH FLOW
Cash From Operating Activities	-$610.0K	-$5.610M	-$140.0K
Capital Expenditures	-$530.0K	$1.630M	-$260.0K
Free Cash Flow	-$80.00K	-$7.240M	$120.0K
YoY Change	-166.67%	308.35%	-93.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-46000
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-334000
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9162565	shares
CY2016Q4	dei	Entity Public Float EntityPublicFloat	8469044
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	617499	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.92
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-334000
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3587000
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	548999	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.71
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33318000
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2770000
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-374000
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-374000
CY2015Q2	us-gaap	Assets Assets	57128000
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5974000
CY2015Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	848000
CY2015Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1476000
CY2015Q2	us-gaap	Former Gain Contingency Recognized In Current Period FormerGainContingencyRecognizedInCurrentPeriod	753000
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	470142	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.73
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	590142	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.46
CY2015Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	33560000
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	991000
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1883000
CY2016Q2	us-gaap	Assets Current AssetsCurrent	17892000
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20920000
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	13539000
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3391000
CY2016Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	7157000
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-420000
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-420000
CY2016Q2	us-gaap	Assets Assets	44105000
CY2016Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2461000
CY2016Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	14286000
CY2016Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	32000
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3261000
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9444000	shares
CY2016Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9444000	shares
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	4722000
CY2016Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2147000
CY2016Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12974000
CY2016Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2322000
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	136000
CY2016Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	624000
CY2016Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1698000
CY2016Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8529000
CY2016Q2	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Remainder Of Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear	140000
CY2016Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	826000
CY2016Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	10652000
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	282000
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	714000
CY2016Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-757000
CY2016Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1583000
CY2016Q2	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-757000
CY2016Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	7633000
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	13103000
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1571000
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2872000
CY2016Q2	us-gaap	Former Gain Contingency Recognized In Current Period FormerGainContingencyRecognizedInCurrentPeriod	-100000
CY2016Q2	us-gaap	Goodwill Goodwill	461000
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2695000
CY2016Q2	us-gaap	Inventory Net InventoryNet	2612000
CY2016Q2	us-gaap	Land Land	1155000
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44105000
CY2016Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2745000
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4565000
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	20051000
CY2016Q2	us-gaap	Long Term Debt LongTermDebt	11188000
CY2016Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	7473000
CY2016Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2979000
CY2016Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	18473000
CY2016Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	13219000
CY2016Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1687000
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	732000
CY2016Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	425000
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2016Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2016Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2768000
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12994000
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	33914000
CY2016Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	6166000
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1648000
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	530642	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.16
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	635642	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.07
CY2016Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19489000
CY2016Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	736000
CY2016Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	1161000
CY2016Q2	ssy	Deferred Tax Assets Accrued Expenses DeferredTaxAssetsAccruedExpenses	1155000
CY2016Q2	ssy	Prepaid Accrued Benefit Cost PrepaidAccruedBenefitCost	-81000
CY2016Q2	ssy	Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost	-81000
CY2016Q2	ssy	Deferred Tax Assets Depreciation Expense DeferredTaxAssetsDepreciationExpense	11000
CY2016Q2	ssy	Defined Benefit Plans Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax DefinedBenefitPlansAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax	676000
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	552000
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	658000
CY2017Q2	us-gaap	Assets Current AssetsCurrent	22621000
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18319000
CY2017Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	0
CY2017Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7751000
CY2017Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	98000
CY2017Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	59000
CY2017Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	62000
CY2017Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	891000
CY2017Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11120000
CY2017Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	61000
CY2017Q2	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	65000
CY2017Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	6458000
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-327000
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-327000
CY2017Q2	us-gaap	Assets Assets	35336000
CY2017Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0
CY2017Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	12107000
CY2017Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	12000
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10494000
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	12000000	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9163000	shares
CY2017Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9163000	shares
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	4581000
CY2017Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	2218000
CY2017Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11120000
CY2017Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	59000
CY2017Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	0
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	231000
CY2017Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	153000
CY2017Q2	us-gaap	Defined Benefit Plan Amounts Recognized In Balance Sheet DefinedBenefitPlanAmountsRecognizedInBalanceSheet	-615000
CY2017Q2	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	1506000
CY2017Q2	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-615000
CY2017Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2098000
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	9000
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	117000
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	26000
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	21000
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	26000
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	100000
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	117000
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	407000
CY2017Q2	us-gaap	Former Gain Contingency Recognized In Current Period FormerGainContingencyRecognizedInCurrentPeriod	64000
CY2017Q2	us-gaap	Goodwill Goodwill	0
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	7203000
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1587000
CY2017Q2	us-gaap	Inventory Net InventoryNet	2159000
CY2017Q2	us-gaap	Land Land	902000
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35336000
CY2017Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0
CY2017Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1329000
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	12314000
CY2017Q2	us-gaap	Long Term Debt LongTermDebt	7203000
CY2017Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	7203000
CY2017Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	6710000
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0
CY2017Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0
CY2017Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	15600000
CY2017Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2425000
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	322000
CY2017Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1277000
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1464000
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	370000
CY2017Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11600000
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	838000
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	289000
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	548000
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	48000
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	176000
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2017Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3062000
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10290000
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28609000
CY2017Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	5906000
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1000000
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4336000
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	620142	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.81
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	680142	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.80
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21693000
CY2017Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	493000
CY2017Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	1040000
CY2017Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Two LongTermDebtContractualCommitmentsForInterestInYearTwo	0
CY2017Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year After Five Year LongTermDebtContractualCommitmentsForInterestInYearAfterFiveYear	0
CY2017Q2	ssy	Deferred Tax Assets Accrued Expenses DeferredTaxAssetsAccruedExpenses	963000
CY2017Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Five LongTermDebtContractualCommitmentsForInterestInYearFive	0
CY2017Q2	ssy	Prepaid Accrued Benefit Cost PrepaidAccruedBenefitCost	-90000
CY2017Q2	ssy	Long Term Debt Contractual Commitments LongTermDebtContractualCommitments	423000
CY2017Q2	ssy	Defined Benefit Plan Amounts Recognized In Prepaid Benefit Cost DefinedBenefitPlanAmountsRecognizedInPrepaidBenefitCost	-90000
CY2017Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Three LongTermDebtContractualCommitmentsForInterestInYearThree	0
CY2017Q2	ssy	Long Term Debt Contractual Commitments For Interest In Next Twelve Months LongTermDebtContractualCommitmentsForInterestInNextTwelveMonths	423000
CY2017Q2	ssy	Plan Expected To Pay In Pension Benefits Through Three Years PlanExpectedToPayInPensionBenefitsThroughThreeYears	449000
CY2017Q2	ssy	Long Term Debt Contractual Commitments For Interest In Year Four LongTermDebtContractualCommitmentsForInterestInYearFour	0
CY2017Q2	ssy	Deferred Tax Assets Depreciation Expense DeferredTaxAssetsDepreciationExpense	-255000
CY2017Q2	ssy	Plans Assets Invested In Equity Investments PlansAssetsInvestedInEquityInvestments	0.29	pure
CY2017Q2	ssy	Plans Assets Invested In Cash And Short Term Investments PlansAssetsInvestedInCashAndShortTermInvestments	0.56	pure
CY2017Q2	ssy	Plans Assets Invested In Fixed Income Investments PlansAssetsInvestedInFixedIncomeInvestments	0.15	pure
CY2017Q2	ssy	Defined Benefit Plans Accumulated Other Comprehensive Income Minimum Pension Liability Before Tax DefinedBenefitPlansAccumulatedOtherComprehensiveIncomeMinimumPensionLiabilityBeforeTax	525000
CY2016Q4	ssy	Shareholder Threshold Percentage ShareholderThresholdPercentage	0.049	pure
CY2015Q1	us-gaap	Insurance Recoveries InsuranceRecoveries	1000000
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	89500	shares
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.15
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.71
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21000	shares
CY2014	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	0.71
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	37000
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37000
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	142000
CY2015	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	2266000
CY2015	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-664000
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2387000
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	205000
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	38000
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	21042000
CY2015	us-gaap	Cost Of Services CostOfServices	3616000
CY2015	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0000	pure
CY2015	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0	pure
CY2015	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1837000
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	855000
CY2015	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2015	us-gaap	Depreciation Depreciation	1695000
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2681000
CY2015	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-218000
CY2015	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	732000
CY2015	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-242000
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2015	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	-3000
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	21000
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2015	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	3678000
CY2015	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	21000
CY2015	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2015	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	487000
CY2015	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.05
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-242000
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.02
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	57000
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	469000
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	12000
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	215000
CY2015	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	116000
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1899000
CY2015	us-gaap	Insurance Recoveries InsuranceRecoveries	1000000
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	81000
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	20000
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1380000
CY2015	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.05
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.02
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	893000
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	279000
CY2015	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-444000
CY2015	us-gaap	Interest Expense InterestExpense	861000
CY2015	us-gaap	Interest Paid InterestPaid	914000
CY2015	us-gaap	Labor And Related Expense LaborAndRelatedExpense	33620000
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4811000
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5362000
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2938000
CY2015	us-gaap	Net Income Loss NetIncomeLoss	245000
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	2220000
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-40000
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-40000
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	818000
CY2015	ssy	Deposit Of Restricted Cash DepositOfRestrictedCash	0
CY2015	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	-40000
CY2015	ssy	Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss	29000
CY2015	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	6893000
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1235000
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	34000
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	175000
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	363000
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	695000
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	73746000
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	37000
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0203	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	48857	shares
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.49
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.50
CY2015	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.49
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.84	pure
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	90000	shares
CY2015	us-gaap	Supplies Expense SuppliesExpense	4366000
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9496000	shares
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	53000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2015	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	25000
CY2015	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-1660000
CY2015	ssy	Financial And Healthcare Services Revenue FinancialAndHealthcareServicesRevenue	77424000
CY2015	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	1235000
CY2015	ssy	Incentive Payments Received Repaid IncentivePaymentsReceivedRepaid	21000
CY2015	ssy	Health Care Organization Significant Change In Estimates HealthCareOrganizationSignificantChangeInEstimates	-540000
CY2015	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	78000
CY2015	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	557000
CY2015	ssy	Repayments Of Long Term Debt Discontinued Operations RepaymentsOfLongTermDebtDiscontinuedOperations	4842000
CY2015	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	1.49
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	64000
CY2017	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1355000
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	36000	shares
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	64000
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	142000
CY2017	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	0
CY2017	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> <b><i>Concentrations of Credit Risk</i></b>—SunLink’s Healthcare Services segment subsidiaries grant unsecured credit to their patients, most of who reside in the service area of the subsidiaries’ facilities and are insured under third-party agreements. Medicare and Medicaid patient accounts represent SunLink’s only significant concentrations of credit risk. For SunLink’s Healthcare Services segment, Medicare net revenues were approximately 40%, 37%, and 39% of net revenues for the years ended June 30, 2017, 2016 and 2015, respectively. For SunLink’s Healthcare Services segment, Medicaid was approximately 43%, 37%, and 30% of net revenues for the years ended June 30, 2017, 2016 and 2015, respectively. For SunLink’s Healthcare Services segment, Medicare receivables were approximately 53% and 51% of receivables—net at June 30, 2017 and 2016, respectively, while Medicaid receivables were approximately 24% and 22% of receivables—net at June 30, 2017 and 2016, respectively.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> SunLink’s Pharmacy segment subsidiary grants unsecured credit to individual customers and institutional customers. Individual customers primarily are insured under third-party agreements, including Medicare and Medicaid, while the institutional customers are grant credit according to their determined credit risk. Medicare receivables were approximately 19%, 13% and 18% of the Pharmacy’s receivables at June 30, 2017, 2016 and 2015, respectively, while Medicaid receivables were approximately 19%, 10% and 12% of the segments receivable at June 30, 2017, 2016 and 2015, respectively. Approximately 62%, 77% and 70% of the Pharmacy’s net receivables at June 30, 2017, 2016 and 2015, respectively, were private insurance and institutional customers’ receivables. Net revenues for the Pharmacy segment for the fiscal year ended June 30, 2017, 2016 and 2015 were approximately 35%, 16% and 8% Medicare, respectively, and approximately 23%, 10% and 14% Medicaid, respectively.</p> </div>
CY2017	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-131000
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	7233000
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2781000
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	54000
CY2017	us-gaap	Cost Of Goods Sold CostOfGoodsSold	19917000
CY2017	us-gaap	Cost Of Services CostOfServices	2767000
CY2017	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2017	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	3000
CY2017	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0000	pure
CY2017	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	140000
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1914000
CY2017	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-53000
CY2017	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-566000
CY2017	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0350	pure
CY2017	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	54000
CY2017	us-gaap	Depreciation Depreciation	1845000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1987000
CY2017	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	-78000
CY2017	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	211000
CY2017	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	0
CY2017	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	4647000
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Type DocumentType	10-K
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2017	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	2829000
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2017	dei	Entity Registrant Name EntityRegistrantName	SUNLINK HEALTH SYSTEMS INC
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0000096793
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2916000
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-243000
CY2017	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	478000
CY2017	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	2917000
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	1427000
CY2017	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1959000
CY2017	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.21
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	4647000
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.50
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	134000
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-840000
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	22000
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	468000
CY2017	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	-154000
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3119000
CY2017	us-gaap	Insurance Recoveries InsuranceRecoveries	0
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-8000
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-453000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2471000
CY2017	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.21
CY2017	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.50
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-512000
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	155000
CY2017	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-260000
CY2017	us-gaap	Interest Expense InterestExpense	635000
CY2017	us-gaap	Interest Paid InterestPaid	570000
CY2017	us-gaap	Labor And Related Expense LaborAndRelatedExpense	23378000
CY2017	us-gaap	Malpractice Insurance Description MalpracticeInsuranceDescription	Claim made under its insurance policy covering, among other things, employee theft relating to misappropriation of funds by two now former employees over an eight year period beginning in 2006.
CY2017	us-gaap	Nature Of Operations NatureOfOperations	<div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="4%" valign="top" align="left"><b>1.</b></td> <td align="left" valign="top"><b>BUSINESS OPERATIONS</b></td> </tr> </table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> SunLink Health Systems, Inc., through subsidiaries (“SunLink”, “we”, “our”, “ours”, “us” or the “Company”), owns businesses which are providers of healthcare services in certain markets in the United States. SunLink’s business is composed of the ownership of two business segments:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">  </p> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="3%" valign="top" align="left">•</td> <td width="1%" valign="top"> </td> <td align="left" valign="top">The Healthcare Services segment, which is composed of:</td> </tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">  </p> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="4%"> </td> <td width="3%" valign="top" align="left">•</td> <td width="1%" valign="top"> </td> <td align="left" valign="top">A subsidiary which owns and operates an <font style="white-space:nowrap"><font style="white-space:nowrap">84-licensed-bed,</font></font> acute care hospital, which includes an <font style="white-space:nowrap">18-bed</font> GPU, and a <font style="white-space:nowrap">66-bed</font> nursing home.</td> </tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">  </p> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="4%"> </td> <td width="3%" valign="top" align="left">•</td> <td width="1%" valign="top"> </td> <td align="left" valign="top">A subsidiary which owns and operates a <font style="white-space:nowrap">100-bed</font> nursing home. This subsidiary also owns a hospital facility and leases the emergency department to an outside third party.</td> </tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">  </p> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="4%"> </td> <td width="3%" valign="top" align="left">•</td> <td width="1%" valign="top"> </td> <td align="left" valign="top">Three subsidiaries which own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land.</td> </tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">  </p> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="4%"> </td> <td width="3%" valign="top" align="left">•</td> <td width="1%" valign="top"> </td> <td align="left" valign="top">A subsidiary which provides information technology (IT) to outside customers and to SunLink subsidiaries</td> </tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The Pharmacy segment, which is composed of four operational areas:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">  </p> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="4%"> </td> <td width="3%" valign="top" align="left">•</td> <td width="1%" valign="top"> </td> <td align="left" valign="top">Retail pharmacy products and services, all of which are conducted in rural markets;</td> </tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">  </p> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="4%"> </td> <td width="3%" valign="top" align="left">•</td> <td width="1%" valign="top"> </td> <td align="left" valign="top">Institutional pharmacy services;</td> </tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">  </p> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="4%"> </td> <td width="3%" valign="top" align="left">•</td> <td width="1%" valign="top"> </td> <td align="left" valign="top">Pharmacy services; and</td> </tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">  </p> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr style="page-break-inside:avoid"> <td width="4%"> </td> <td width="3%" valign="top" align="left">•</td> <td width="1%" valign="top"> </td> <td align="left" valign="top">Durable medical equipment.</td> </tr> </table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> SunLink subsidiaries have conducted the Healthcare Services business since 2001 and the Pharmacy operations since 2008. Our Pharmacy segment currently is operated through Carmichael’s Cashway Pharmacy, Inc. (“Carmichael”), a subsidiary of our SunLink ScriptsRx, LLC subsidiary, and is composed of a pharmacy business acquired in April 2008 with four service lines.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> Throughout these notes to the consolidated financial statements, SunLink Health Systems, Inc., and its consolidated subsidiaries are referred to on a collective basis as “SunLink”, “we”, “our”, “ours”, “us” or the “Company.” This drafting style is not meant to indicate that the publicly traded Company or any particular subsidiary of the Company owns or operates any asset, business or property. The Trace Hospital, pharmacy operations and businesses described in this filing are owned and operated by distinct and indirect subsidiaries of SunLink Health System, Inc.</p> </div>
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	18469000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5626000
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5610000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	2688000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-4510000
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	93000
CY2017	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	93000
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	561000
CY2017	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	5616000
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	641000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1630000
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5478000
CY2017	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	Estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis.
CY2017	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2017	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	Depreciation is recognized over the estimated useful lives of the assets, which range from 3 to 45 years, on a straight-line basis.
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	438000
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3985000
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	636000	shares
CY2017	us-gaap	Sales Revenue Net SalesRevenueNet	53288000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.87	pure
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	72000	shares
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	64000
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0130	pure
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y8M26D
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	27500	shares
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.21
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.55
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.21
CY2017	us-gaap	Supplies Expense SuppliesExpense	1844000
CY2017	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	641000
CY2017	dei	Trading Symbol TradingSymbol	SSY
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9346000	shares
CY2017	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> <b><i>Management Estimates</i></b>—The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates made by management involve reserves for adjustments to net patient service revenues, evaluation of the recoverability of assets, including accounts receivable and intangible assets, and the assessment of litigation and contingencies, including income taxes and related tax asset valuation allowances, all as discussed in more detail in the remainder of these notes to the consolidated financial statements. Actual results could differ materially from these estimates.</p> </div>
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9346000	shares
CY2017	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	58000
CY2017	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	1224000
CY2017	ssy	Financial And Healthcare Services Revenue FinancialAndHealthcareServicesRevenue	53766000
CY2017	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	1630000
CY2017	ssy	Incentive Payments Received Repaid IncentivePaymentsReceivedRepaid	64000
CY2017	ssy	Health Care Organization Significant Change In Estimates HealthCareOrganizationSignificantChangeInEstimates	193000
CY2017	ssy	Deposit Of Restricted Cash DepositOfRestrictedCash	1000000
CY2017	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	93000
CY2017	ssy	Defined Contribution Plan Employer Matching Contribution DefinedContributionPlanEmployerMatchingContribution	152000
CY2017	ssy	Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss	64000
CY2017	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	0
CY2017	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	2321000
CY2017	ssy	Repayments Of Long Term Debt Discontinued Operations RepaymentsOfLongTermDebtDiscontinuedOperations	0
CY2017	ssy	Unrecognized Actuarial Loss UnrecognizedActuarialLoss	525000
CY2017	ssy	Net Operating Loss Carryforward Expiration Year NetOperatingLossCarryforwardExpirationYear	2024
CY2017	ssy	Maximum Period Of Accounts Receivable Written Off MaximumPeriodOfAccountsReceivableWrittenOff	P120D
CY2017	ssy	Age Of Participants To Take Monthly Pension Benefits One AgeOfParticipantsToTakeMonthlyPensionBenefitsOne	P65Y
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	58000
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	142000
CY2016	us-gaap	Charity Care Reimbursements Received CharityCareReimbursementsReceived	1801000
CY2016	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	729000
CY2016	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	858000
CY2016	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-11914000
CY2016	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.26
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.49
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2713000
CY2016	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	15000
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14129000
CY2016	us-gaap	Health Care Organization Patient Service Revenue Provisionfor Bad Debts HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts	1438000
CY2016	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	10000
CY2017	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	1.21
CY2017	ssy	Share Based Payment Award Options Forfeited In Period Range Of Exercise Price ShareBasedPaymentAwardOptionsForfeitedInPeriodRangeOfExercisePrice	6.55
CY2017	ssy	Expected Return On Investment ExpectedReturnOnInvestment	0.04	pure
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	58000
CY2016	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	3712000
CY2016	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-93000
CY2016	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax	-2169000
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.49
CY2016	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod	0
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2000
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	20404000
CY2016	us-gaap	Cost Of Services CostOfServices	3248000
CY2016	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	0
CY2016	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	-23000
CY2016	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.0000	pure
CY2016	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	128000
CY2016	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0	pure
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1878000
CY2016	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	169000
CY2016	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Expected Long Term Return On Assets DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets	0.0400	pure
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4556000
CY2016	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate	0.0450	pure
CY2016	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	65000
CY2016	us-gaap	Depreciation Depreciation	1736000
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2436000
CY2016	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	-127000
CY2016	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	-2169000
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2169000
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.23
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	78000
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2501000
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	20000
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7350000
CY2016	us-gaap	Income Tax Reconciliation Tax Settlements State And Local IncomeTaxReconciliationTaxSettlementsStateAndLocal	-405000
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	312000
CY2016	us-gaap	Insurance Recoveries InsuranceRecoveries	0
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	94000
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-536000
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7356000
CY2016	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.26
CY2016	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-46000
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	791000
CY2016	ssy	Increase Decrease In Third Party Payor Settlements IncreaseDecreaseInThirdPartyPayorSettlements	-3009000
CY2016	ssy	Financial And Healthcare Services Revenue FinancialAndHealthcareServicesRevenue	64871000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	29500	shares
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.79
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	9.15
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.23
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.79
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4558000
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	309000
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.80	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	75000	shares
CY2016	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-1513000
CY2016	us-gaap	Supplies Expense SuppliesExpense	3326000
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2016	us-gaap	Interest Expense InterestExpense	843000
CY2016	us-gaap	Interest Paid InterestPaid	768000
CY2016	us-gaap	Labor And Related Expense LaborAndRelatedExpense	30783000
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1430000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-857000
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-426000
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-14083000
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-6523000
CY2016	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2016	ssy	Other Comprehensive Income Minimum Pension Liabilities Net Adjustment Tax OtherComprehensiveIncomeMinimumPensionLiabilitiesNetAdjustmentTax	28000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.15
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0163	pure
CY2016	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	8031000
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1347000
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	21000
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	630000
CY2016	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	857000
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	63433000
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	58000
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00	pure
CY2016	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	1347000
CY2016	ssy	Incentive Payments Received Repaid IncentivePaymentsReceivedRepaid	-7000
CY2016	ssy	Health Care Organization Significant Change In Estimates HealthCareOrganizationSignificantChangeInEstimates	780000
CY2016	ssy	Deposit Of Restricted Cash DepositOfRestrictedCash	0
CY2016	ssy	Other Comprehensive Income Loss Minimum Pension Liability Adjustment Net Of Tax OtherComprehensiveIncomeLossMinimumPensionLiabilityAdjustmentNetOfTax	-46000
CY2016	ssy	Health Care Organization Medicare And Medicaid Electronic Health Records Incentives Gain Loss HealthCareOrganizationMedicareAndMedicaidElectronicHealthRecordsIncentivesGainLoss	-7000
CY2016	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	104000
CY2016	ssy	Increase Decrease Changes In Deferred Income Taxes IncreaseDecreaseChangesInDeferredIncomeTaxes	4530000
CY2016	ssy	Repayments Of Long Term Debt Discontinued Operations RepaymentsOfLongTermDebtDiscontinuedOperations	0
CY2016	ssy	Unrecognized Actuarial Loss UnrecognizedActuarialLoss	676000
CY2016	ssy	Share Based Compensation Arrangement By Share Based Payments Award Options Grants In Period Range Of Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentsAwardOptionsGrantsInPeriodRangeOfExercisePrice	1.79
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2017Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-890000
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.10
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-1025000
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	13699000
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9334000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9334000	shares
	ssy	Number Of Hospitals Sold NumberOfHospitalsSold	3	Hospital
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2016Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1392000
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.15
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-1835000
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	16205000
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2016Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-823000
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2016Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-1234000
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	14060000
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2017Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2768000
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.30
CY2017Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.30
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-2408000
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	12288000
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9163000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9163000	shares
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.18
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2015Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1133000
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.12
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-1668000
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	16583000
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.99
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.99
CY2015Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-8566000
CY2015Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.91
CY2015Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.91
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-9346000
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet	16585000
CY2015Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2015Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2016Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1250000
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.13
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.13
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	3023000
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	13046000
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9443000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2016Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2949000
CY2016Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.31
CY2016Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.31
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	3098000
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	14255000
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9450000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9443000	shares

Files In Submission

Name	View Source	Status
0001193125-17-297905-index-headers.html	Edgar Link	pending
0001193125-17-297905-index.html	Edgar Link	pending
0001193125-17-297905.txt	Edgar Link	pending
0001193125-17-297905-xbrl.zip	Edgar Link	pending
d413699d10k.htm	Edgar Link	pending
d413699dex211.htm	Edgar Link	pending
d413699dex231.htm	Edgar Link	pending
d413699dex311.htm	Edgar Link	pending
d413699dex312.htm	Edgar Link	pending
d413699dex321.htm	Edgar Link	pending
d413699dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g413699g09p43.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssy-20170630.xml	Edgar Link	completed
ssy-20170630.xsd	Edgar Link	pending
ssy-20170630_cal.xml	Edgar Link	unprocessable
ssy-20170630_def.xml	Edgar Link	unprocessable
ssy-20170630_lab.xml	Edgar Link	unprocessable
ssy-20170630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

2017 Q2 Form 10-K Financial Statement

#000119312517297905 Filed on September 28, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY SUNLINK HEALTH SYSTEMS INC Stock $ssy

2017 Q2 Form 10-K Financial Statement

#000119312517297905 Filed on September 28, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy